Abstract
Value of Minimal Residual Disease (MRD) Negative Status at Response Evaluation in Chronic Lymphocytic Leukemia (CLL): Combined Analysis of Two Phase III Studies of the German CLL Study Group (GCLLSG)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have